Trials / Completed
CompletedNCT01011452
Acute Montelukast in Asthma
Assessment of the Effect of Oral Montelukast as Additional Treatment in the Management of Patients With Acute Severe Asthma.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 87 (actual)
- Sponsor
- University of East Anglia · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Patients presenting to hospital with an acute asthma exacerbation severe enough to require admission would receive full standard treatment according to British Thoracic Society guidelines in addition they would be offered the opportunity to take part in the study which would requite them to take a capsule of either montelukast or placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Montelukast | 1 study capsule at study entry Montelukast 10mg and a further study capsule at 10pm for four weeks |
| DRUG | Placebo | 1 placebo capsule at study entry and a further placebo capsule at 10pm for four weeks |
Timeline
- Start date
- 2001-05-01
- Primary completion
- 2004-08-01
- Completion
- 2004-10-01
- First posted
- 2009-11-11
- Last updated
- 2009-11-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01011452. Inclusion in this directory is not an endorsement.